Nurix Therapeutics, Inc. NRIX Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax, Current
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax, Current at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept nrix:DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTaxCurrent.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s debt securities, available-for-sale, accumulated gross unrealized loss, before tax, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s debt securities, available-for-sale, accumulated gross unrealized loss, before tax, current?
- Nurix Therapeutics, Inc. (NRIX) reported debt securities, available-for-sale, accumulated gross unrealized loss, before tax, current of $32K in Q4 2025.
- What does debt securities, available-for-sale, accumulated gross unrealized loss, before tax, current mean?
- This metric tracks the total accumulated gross unrealized losses on current debt securities before tax considerations. It identifies the extent to which the company's short-term investment portfolio is currently trading below its cost basis. This is a key indicator of market risk affecting the company's liquid assets.